Publications of Elisabeth Binder

Conference Paper (1)

2017
Conference Paper
Zannas, A.; Jia, M.; Baumert, J.; Hafner, K.; Ködel, M.; Hähle, A.; Iurato, S.; Carrillo Roa, T.; Emeny, R.; Lathi, J. et al.; Raikkonen, K.; Eriksson, J.; Drake, A.; Waldenberger, M.; Wahl, S.; Kunze, S.; Lucae, S.; Bradley, B.; Gieger, C.; Hausch, F.; Smith, A.; Ressler, K.; Müller-Myhsok, B.; Ladwig, K.-H.; Rein, T.; Gassen, N.; Binder, E.: Aging- and Stress-Related Epigenetic Disinhibition of FKBP5 Contributes to NF-KB-Driven Inflammation and Cardiovascular Risk. 56th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), Palm Springs, CA, December 03, 2017 - December 07, 2017. NEUROPSYCHOPHARMACOLOGY 42 (Suppl. 1), T26, pp. S310 - S311 (2017)

Meeting Abstract (34)

2023
Meeting Abstract
Froehlich, A. S.; Gerstner, N.; Gagliardi, M.; Ködel, M.; Matosin, N.; Yusupov, N.; Murek, V.; Czamara, D.; Roeh, S.; Arloth, J. et al.; Ziller, M. J.; Binder, E. B.: CELL-TYPE SPECIFIC AGEING EFFECTS IN THE HUMAN ORBITOFRONTAL CORTEX AND IMPLICATIONS FOR PSYCHIATRIC DISEASE. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 75, pp. S25 - S26. World Congress of Psychiatric Genetics (WCPG), Montreal, CANADA, October 10, 2023 - October 14, 2023. (2023)
Meeting Abstract
Karlbauer, V.; Czamara, D.; Martins, J.; Rex-Haffner, M.; Entringer, S.; Winter, S.; Buss, C.; Heim, C.; Binder, E. B.: TARGETED BISULFITE SEQUENCING REVEALS DRIVERS OF FKBP5 METHYLATION IN MALTREATED AND NON-MALTREATED CHILDREN. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 75, pp. S173 - S174. World Congress of Psychiatric Genetics (WCPG), Montreal, CANADA, October 10, 2023 - October 14, 2023. (2023)
Meeting Abstract
Yusupov, N.; Dieckmann, L.; Erhart, M.; Sauer, S.; Rex-Haffner, M.; Kopf-Beck, J.; Brueckl, T.; Czamara, D.; Binder, E.: Transdiagnostic Evaluation of Epigenetic Age Acceleration and Burden of Psychiatric Disorders. In BIOLOGICAL PSYCHIATRY, 93 (9), p. S166 - S166. (2023)
2022
Meeting Abstract
Palma-Gudiel, H.; Marques Feixa, L.; Romero, S.; Rapado-Castro, M.; Blasco-Fontecilla, H.; Zorrilla, I.; Martin, M.; Quintas, A. C.; Monteserin-Garcia, J. L.; Font, E. et al.; Ramirez, M.; Moreno, D.; Marin-Vila, M.; Moreno, N.; Binder, E.; Fananas, L.: Children and adolescents exposed to maltreatment already exhibit epigenetic patterns suggestive of heightened low-grade inflammation. In EUROPEAN PSYCHIATRY, 65, p. S71 - S71. (2022)
Meeting Abstract
Binder, E.: Has Clinical Translation of Scientific Research been a Failure? In EUROPEAN PSYCHIATRY, 65, pp. S6 - S7. (2022)
Meeting Abstract
Gerstner, N.; Krontira, A.; Knauer-Arloth, J.; Binder, E. B.: Brain region specific effects on the expression of glucocorticoid receptor-regulated genes. In EUROPEAN JOURNAL OF HUMAN GENETICS, 30 (SUPPL 1), p. 301 - 301. (2022)
2021
Meeting Abstract
Fietz, J.; Pöhlchen, D.; Brueckl, T. M.; Padberg, F.; Binder, E. B.; Czisch, M.; Saemann, P.; Spoormaker, V. I.: Patient stratification based on pupillometric response profiles and its brain correlates in affective and anxiety disorders. In JOURNAL OF NEURAL TRANSMISSION, 128 (11), p. 1773 - 1773. (2021)
Meeting Abstract
Binder, E.: EMBEDDING OF EARLY ADVERSITY, MOLECULAR MECHANISMS AND GENETIC MODERATION - IMPLICATIONS FOR RISK TRAJECTORIES IN PSYCHIATRY. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 51, p. E2 - E2. (2021)
Meeting Abstract
Dieckmann, L.; Cruceanu, C.; Lahti-Pulkkinen, M.; Kvist, T.; Lahti, J.; Sammallahti, S.; Graebig-Rancourt, R. C.; Plagemann, A.; Eriksson, J. G.; Kajantie, E. et al.; Braun, T.; Entringer, S.; Raikkonen, K.; Binder, E. B.; Czamara, D.: APPLICATION OF REFERENCE-BASED CELL TYPE ESTIMATION IN PLACENTAL TISSUE AND COMPARISON WITH A REFERENCE-FREE APPROACH FOR DNA METHYLATION STUDIES. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 51, pp. E216 - E217. (2021)
2019
Meeting Abstract
Martinelli, S.; Wiechmann, T.; Kathrin, H.; Meinhold, L.; Roeh, S.; Sauer, S.; Gassen, N.; Binder, E. B.: Unravelling the differential role of FKBP51 (FK506 Binding Protein 5) isoforms in different cellular pathways. In European Neuropsychopharmacology, 29, pp. S652 - S653. ECNP Workshop on Early Career Scientists in Europe, Nice, FRANCE, March 07, 2019 - March 10, 2019. Elsevier, Amsterdam (2019)
Meeting Abstract
Arloth, J.; Eraslan, G.; Andlauer, T.; Gieger, C.; Gold, R.; Heilmann-Heimbach, S.; Kacprowski, T.; Meitinger, T.; Laudes, M.; Luessi, F. et al.; Mueller-Myhsok, B.; Nischwitz, S.; Peters, A.; Paul, F.; Rawal, R.; Strauch, K.; Wiendl, H.; Hemmer, B.; Theis, F.; Binder, E.; Mueller, N.: Identification of functionally relevant genetic variants associated with multiple sclerosis using deep learning. In MULTIPLE SCLEROSIS JOURNAL, 25, pp. 906 - 907. 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, SWEDEN, September 11, 2019 - September 13, 2019. (2019)
Meeting Abstract
Athreya, A. P.; Neavin, D.; Carrillo-Roa, T.; Frye, M. A.; Skime, M.; Rush, A.; Bobo, W. V.; Wang, L.; Binder, E.; Iyer, R. K. et al.; Weinshilboum, R. M.: ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. In CLINICAL PHARMACOLOGY & THERAPEUTICS, 105, pp. S80 - S81. (2019)
Meeting Abstract
Awaloff, Y.; Provencal, N.; Carrillo Roa, T.; Halldorsdottir, T.; Boadie, D.; Mayberg, H.; Craighed, E.; Czamara, D.; Binder, E.: INTERACTIONS BETWEEN GENOTYPE AND ENVIRONMENT HAVE A STRONG EFFECT ON VARIABILITY IN DNA METHYLATION IN PSYCHIATRIC PATIENTS. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, p. S984 - S984. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, October 13, 2017 - October 17, 2017. (2019)
Meeting Abstract
Binder, E.; Burmeister, M.: MECHANISMS OF EARLY ADVERSITY ASSOCIATED INCREASES IN RISK FOR PSYCHIATRIC DISORDERS. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, pp. S746 - S747. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, October 13, 2017 - October 17, 2017. (2019)
Meeting Abstract
Breen, M.; Tylee, D.; Maihofer, A.; Tsuang, M.; Chandler, S.; Mehta, D.; Binder, E.; Hess, J.; Baker, D.; Risbrough, V. et al.; Nievergelt, C.; Buxbaum, J.; Glatt, S.: PTSD BLOOD TRANSCRIPTOME MEGA-ANALYSIS: INFLAMMATORY PATHWAYS ACROSS BIOLOGICAL SEX AND MODES OF TRAUMA. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, pp. 1056 - 1057. 26th World Congress of Psychiatric Genetics (WCPG), Glasgow, SCOTLAND, October 11, 2018 - October 15, 2018. (2019)
Meeting Abstract
Czamara, D.; Eraslan, G.; Lahti, J.; Figueiredo, A. S.; Girchenko, P.; Lahti-Pulkkinen, M.; Hamalainen, E.; Kajantie, E.; Laivuori, H.; Villa, P. et al.; Reynolds, R.; Mueller, N.; Theis, F. J.; Raikkonen, K.; Binder, E.: GENOTYPE, PRENATAL ENVIRONMENT OR BOTH-WHAT SHAPES THE NEWBORN'S EPIGENOME? In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, p. 1037 - 1037. 26th World Congress of Psychiatric Genetics (WCPG), Glasgow, SCOTLAND, October 11, 2018 - October 15, 2018. (2019)
Meeting Abstract
Czamara, D.; Eraslan, G.; Suarez, A.; Girchenko, P.; Lahti, J.; Lahti, M.; Hamalainen, E.; Kajantie, E.; Laivuori, H.; Reynolds, R. M. et al.; Kondofersky, I.; Mueller, N. S.; Theis, F. J.; Raikkonen, K.; Binder, E. B.: WHAT SHAPES THE CHILD'S EPIGENOME: GENOTYPE, PRENATAL ENVIRONMENT OR BOTH? In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, p. S985 - S985. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, October 13, 2017 - October 17, 2017. (2019)
Meeting Abstract
Dammering, F.; Martins, J.; Hoffmann, F.; Provencal, N.; de Punder, K.; Overfeld, J.; Czamara, D.; Rex-Haffner, M.; McEwen, L.; Kobor, M. et al.; Winter, S.; Buss, C.; Entringer, S.; Binder, E.; Heim, C.: Psychiatric symptom severity mediates the effect of adversity on epigenetic aging in children aged 3-5 years. In PSYCHONEUROENDOCRINOLOGY, 107, p. 30 - 30. 49th Annual Conference of the International-Society-of-Psychoneuroendocrinology - 50 Years of Psychoneuroendocrinology - Returning to Where It All Began, Milan, ITALY, August 29, 2019 - August 31, 2019. (2019)
Meeting Abstract
de Punder, K.; Overfeld, J.; Karaboycheva, G.; Winter, S.-M.; Buss, C.; Binder, E. B.; Heim, C.: Elevated C-reactive protein levels in children aged 3-5 years with verified exposure to maltreatment: Sex differences and association with depressive symptoms. In PSYCHONEUROENDOCRINOLOGY, 100, pp. S23 - S24. 48th Annual Conference of the International-Society-of-Psychoneuroendocrinology (ISPNE), Irvine, CA, September 06, 2018 - September 08, 2018. (2019)
Go to Editor View